Depression is a common mood disorder that belongs to high incidence mental diseases worldwide. Its main clinical features are a state of low mood and aversion to activity, and sometimes even suicidal thoughts or behaviors. According to statistics from World Health Organization (WHO), depression is one of the most disabling diseases in the world today with over 0.3 billion sufferers worldwide. Because there are 10 to 20 million patients with suicidal thoughts every year in the world, it is said that 21 century is a "Century of Depression". China is going through social transformation, which is also a period with high incidence of psychological problems. Statistics shows that there are more than 30 million depression patients now in China, of which over 80% have never been treated because of low income or other issues. Depression patients take up 50% to 70% of suicides and attempted suicides in China. Obviously, depression has become a major social problem in China. Since Eli Lilly and Company first launched duloxetine (brand name "Cymbalta") in August 2004, its sales revenue has been continually increasing, which nearly reached USD 5 billion in 2012. Inquire this Report before buying @ http://www.chinamarketresearchreports.com/contacts/inquire-before-buy.php?name=114721 . Complete report spread across [40] pages available @ http://www.chinamarketresearchreports.com/114721.html . Read more on “Investigation Report on China Duloxetine Market, 2009-2018” report below.
Be the first to comment